Home/Hedge Fund Intelligence/Dianthus Therapeutics, Inc.
Nasdaq: DNTHStockForm 13F30 Jun 2026

Hedge funds that hold Dianthus Therapeutics, Inc. Nasdaq: DNTH

CUSIP 252828108 · who reports it, how much, and how much it matters to them

44 of the 720 hedge fund managers we track reported shares of Dianthus Therapeutics, Inc. (Nasdaq: DNTH) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to Fairmount Funds Management, at USD 247m.

Managers reporting it44of 720 we track
Value they reportUSD 1.2bnshares only, 30 Jun 2026
Funds they run480with a file on PPLI.com
Largest positionUSD 247mFairmount Funds Management
Typical weight0.1%median share of a manager's book
Heaviest weight16.3%Fairmount Funds Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

44 managers, USD 1.2bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Dianthus Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Fairmount Funds Management2 funds on PPLI.comUSD 247m16.3%
2Octagon Capital Advisors1 fund on PPLI.comUSD 180m16.1%
3Polar Capital LLP26 funds on PPLI.comUSD 99m0.2%
4Citadel Advisors32 funds on PPLI.comUSD 95m0.0%
5Baker Bros. Advisors2 funds on PPLI.comUSD 83m0.4%
6Logos Global Management1 fund on PPLI.comUSD 78m3.4%
7Cormorant Asset Management1 fund on PPLI.comUSD 73m3.7%
8Braidwell12 funds on PPLI.comUSD 58m2.1%
9Artisan Partners1 fund on PPLI.comUSD 25m0.0%
10RTW Investments2 funds on PPLI.comUSD 24m0.2%
11LMR Partners2 funds on PPLI.comUSD 22m0.1%
12Samlyn Capital8 funds on PPLI.comUSD 19m0.3%
13Adage Capital Management1 fund on PPLI.comUSD 18m0.0%
14Atika Capital Management3 funds on PPLI.comUSD 16m1.1%
15Artia Global Partners1 fund on PPLI.comUSD 16m2.9%
16Balyasny Asset Management25 funds on PPLI.comUSD 16m0.0%
17Eagle Health Investments1 fund on PPLI.comUSD 13m2.1%
18Marshall Wace LLP84 funds on PPLI.comUSD 13m0.0%
19PFM Health Sciences3 funds on PPLI.comUSD 12m1.0%
20Orbimed Advisors1 fund on PPLI.comUSD 11m0.2%
21Two Sigma Investments35 funds on PPLI.comUSD 10m0.0%
22Millennium Management6 funds on PPLI.comUSD 9m0.0%
23Sio Capital Management4 funds on PPLI.comUSD 5.8m1.0%
24HighVista Strategies27 funds on PPLI.comUSD 5m1.1%
25Burkehill Global Management5 funds on PPLI.comUSD 4.9m0.2%
26Schonfeld Strategic Advisors30 funds on PPLI.comUSD 4.2m0.0%
27D. E. Shaw & Co.15 funds on PPLI.comUSD 4.2m0.0%
28Verition Fund Management3 funds on PPLI.comUSD 3.9m0.0%
29Tudor Investment Corporation10 funds on PPLI.comUSD 3.6m0.0%
30Atom Investors1 fund on PPLI.comUSD 3.6m0.3%
31Hudson Bay Capital Management8 funds on PPLI.comUSD 3.5m0.0%
32Aquatic Capital Management3 funds on PPLI.comUSD 2.4m0.1%
33Arrowmark Colorado Holdings24 funds on PPLI.comUSD 2m0.1%
34Rock Springs Capital Management2 funds on PPLI.comUSD 2m0.1%
35Brevan Howard Capital Management39 funds on PPLI.comUSD 1.8m0.0%
36Walleye Capital8 funds on PPLI.comUSD 1.7m0.0%
37Cinctive Capital Management5 funds on PPLI.comUSD 1.3m0.0%
38Engineers Gate Manager1 fund on PPLI.comUSD 1.1m0.0%
39Verdad Advisers6 funds on PPLI.comUSD 981,0000.9%
40Boothbay Fund Management2 funds on PPLI.comUSD 723,0000.0%
41Persistent Asset Partners10 funds on PPLI.comUSD 543,0000.2%
42Entrypoint Capital1 fund on PPLI.comUSD 413,0000.1%
43Capstone Investment Advisors25 funds on PPLI.comUSD 207,0000.0%
44Bayforest Capital1 fund on PPLI.comUSD 196,0000.2%
Next: where it matters most
Where it matters most

For Fairmount Funds Management it is 16.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Fairmount Funds ManagementUSD 247m16.3%
2Octagon Capital AdvisorsUSD 180m16.1%
3Cormorant Asset ManagementUSD 73m3.7%
4Logos Global ManagementUSD 78m3.4%
5Artia Global PartnersUSD 16m2.9%
6BraidwellUSD 58m2.1%
7Eagle Health InvestmentsUSD 13m2.1%
8HighVista StrategiesUSD 5m1.1%
9Atika Capital ManagementUSD 16m1.1%
10PFM Health SciencesUSD 12m1.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Dianthus Therapeutics, Inc.

What is the ticker symbol of Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. trades under the symbol DNTH on the Nasdaq. Its CUSIP, the code used on Form 13F, is 252828108.

Which hedge funds own Dianthus Therapeutics, Inc. (Nasdaq: DNTH)?

44 of the 720 hedge fund managers PPLI.com tracks reported Dianthus Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 247m), Octagon Capital Advisors (USD 180m), Polar Capital LLP (USD 99m), Citadel Advisors (USD 95m) and Baker Bros. Advisors (USD 83m).

How many hedge funds hold Dianthus Therapeutics, Inc.?

44 managers in our coverage reported it, and between them they run 480 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Dianthus Therapeutics, Inc.?

Fairmount Funds Management, where the position was 16.3% of the reported 13F book at 30 June 2026.

Does this show who is short Dianthus Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Dianthus Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.